Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
The pharmaceutical industry faced one of the biggest waves of drug Patent expiration in history. A significant number of top-selling drugs in the history of the pharmaceutical industry will experience patent expirations over the next 5 years, paving the way for lower-priced generics, In total, patents on drugs worth $12 billion expired by the end of 2011, and in 2012 that figure is expected to increase to more than $30 billion in annual sales. The United States between 2007 and 2012 alone, as more than three dozen drugs lose patent protection during this time. Evaluation of Pharma has determined that in 2013, patents will expire on drugs that currently have sales of $29 billion annually. The research firm expects more than 70% of that total will be lost to generics. Falling revenue is usually tracked by a falling share price. When patents expire for brand-name prescription drugs, pharmaceutical manufacturers can produce and sell generic equivalents. Patent expirations up to 2016 will reduce brand spending in worldwide developed markets by $127 billion, but will be counterbalanced by generic spending, resulting in a five-year global savings of close to $106 billion. The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide. At the same time, the balance in terms of healthcare expenditure and sales revenue is poised to shift from developed to emerging markets such as India, China, Brazil, Russia, Turkey and South Korea, as huge potential still remains untapped in these countries. The patent expiration of blockbuster drug fuel the growth of global generic drug pharmaceutical market. Many branded pharmaceutical companies drugs expired in last few years like Lipitor, Cozaar, Concerta, Crestor, Levaquin and Zyprexa. Market leaders such as Teva, Sandoz and Mylan are increasingly focused on generics, as this segment provides a competitive edge and presents huge profit margins. Patent expiration opens the door for generic versions which make the healthcare available to the consumers at cheaper costs as compared to the patented drugs. OMICS Group is an Open Access publishing journals that is responsible for the dissemination of scientific process and research articles to the global community. Its Open Access journals Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Publishing Group having over 300 leading peer reviewed Open Access journals and has organized more than 300 scientific conferences all over the world. OMICS Group has more than 1000 scientific associations and 30,000 editorial board members and 3.5 million readers to its credit. OMICS Group is a pioneer and leading Science event organizer. OMICS Group International Conferences 2014 and 2015 are instrumental in providing a momentous platform for the world renowned scientists, researchers, students, academicians, institutions, entrepreneurs and industries through International Science Conferences. The main vision and mission of OMICS Publishing Group is to provide free access to scientific literature for quick dissemination of scientific updates and it also provides source of reference and retrieval free of cost. OMICS Group organizes International conferences and Annual meetings in association with organizing committees across the world. OMICS Group conferences bring together scientists, researchers and practitioners to discuss methodological innovations, practical applications and new findings in the research areas of Science, Technology and Management. Research fellows and professors in various disciplines submit works in the form of manuscripts which undergo quality check before being approved for publication.
Pharma Patents Conferences in 2015: 1. International Patent Information Conference & Exposition 2. Global Intellectual Property Convention 3. Drug and Medical Device Litigation 4. Trade Secrets Protection & Enforcement 5. Pharma & Biotech Patent Litigation 6. Effective Trade Mark Administration 7. Best Practices For Selling Your Patents 8. Certified Patent Valuation Analyst 9. EU & US Patent Applications Lists of Societies related to pharma: 1) International Society for Pharmaceutical Engineering (ISPE) 2) American Association of Pharmaceutical Scientists (AAPS), USA 3) Austrian Association of Hospital Pharmacists (AAHP), Australia 4) Canadian Society for Pharmaceutical Sciences (CSPS), Canada 5) Chinese Pharmaceutical Association (CPA), China 6) European Federation for Pharmaceutical Sciences (EUFEPS), Europe 7) German Pharmaceutical Society (DPhG), Germany 8) Indian Pharmaceutical Association (IPA), India Major Pharma and related Companies: 1) Pfizer, USA 2) Novartis, Switzerland 3) Merck & Co., USA 4) Bayer, Germany 5) GlaxoSmithKline, U K 6) Johnson & Johnson, USA 7) Sanofi, France 8) Hoffmann–La Roche, Switzerland 9) AstraZeneca, UK 10) Abbott Laboratories, USA 11) Bristol-Myers Squibb, USA 12) Eli Lilly and Company, USA 13) Amgen, USA 14) Takeda Pharmaceutical Co., Japan
This page will be updated regularly.
This page was last updated on 09th Oct, 2014
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising